文献速递血液净化与透析

血液透析动静脉通路位置与使用的国际差异:DOPPS研究结果

International Differences in the Location and Use of Arteriovenous Accesses Created for Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).
PubMed 文献 · Am J Kidney Dis · 2017-12-01

基于DOPPS前瞻性队列,分析美国、日本及欧洲/澳新地区血液透析患者动静脉内瘘(AVF)和移植物(AVG)的位置、成功使用率及成熟时间。发现AVF位置、成功使用率及首次成功使用时间存在显著国际差异,美国下臂AVF比例大幅下降,挑战最佳实践定义。

要点

  • 日本下臂AVF比例持续≥93%,欧洲/澳新65%-77%,美国从70%降至32%。
  • AVF成功使用率:日本87%,欧洲/澳新67%,美国64%;AVG成功使用率:日本86%,欧洲/澳新75%,美国78%。
  • 首次成功使用中位时间:AVF日本10天、欧洲/澳新46天、美国82天;AVG分别为6、24、29天。

核心结论

  • AVF位置、预测因素、成功使用率及首次AVF/AVG使用时间存在大的国际差异,挑战最佳实践的定义。
  • 美国从下臂向上臂AVF的大规模转变引发对部分患者长期健康影响及增加AVF使用政策对AVF放置位置影响的严重担忧。

研究设计与样本

  • 前瞻性队列研究,纳入美国、日本及欧洲/澳新地区参与DOPPS的血液透析患者。
  • 2009-2015年期间,3850例患者接受4247个新AVF,842例患者接受1129个新AVG;AVF位置趋势基于DOPPS 1至5横断面(1996-2015)记录的38868个AVF。

主要发现

  • DOPPS 1至5期间,下臂AVF百分比在日本持续≥93%,欧洲/澳新65%-77%,美国从70%(DOPPS 1)降至32%(DOPPS 5)。
  • 与AVF位置相关的患者特征因地区而异。
  • AVF成功使用率:日本87%,欧洲/澳新67%,美国64%;AVG成功使用率:日本86%,欧洲/澳新75%,美国78%。
  • 美国上臂AVF成功使用率高于下臂,欧洲/澳新差异小,日本相反。
  • 首次成功AVF使用中位时间:日本10天,欧洲/澳新46天,美国82天;AVG:日本6天,欧洲/澳新24天,美国29天。

临床怎么用

  • 临床应认识到AVF位置选择、成功使用率及成熟时间存在显著国际差异,需结合地区实践和患者特征个体化决策。

局限性

  • 多个血液透析机构图表数据抽象可能存在测量误差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vascular access practice is strongly associated with clinical outcomes. There is substantial international variation in the use of arteriovenous fistulas (AVFs) and grafts (AVGs), as well as AVF maturation time and location. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: Hemodialysis patients participating in the prospective Dialysis Outcomes and Practice Patterns Study (DOPPS) from the United States, Japan, and Europe/ANZ (Belgium, France, Germany, Italy, Spain, Sweden, United Kingdom, Australia, and New Zealand), including 3,850 patients receiving 4,247 new AVFs and 842 patients receiving 1,129 new AVGs in 2009 to 2015. AVF location trends were based on 38,868 AVFs recorded in DOPPS 1 to 5 cross-sections (1996-2015). PREDICTORS: Demographics, comorbid conditions, dialysis vintage, body mass index, facility percentage AVF use, median blood flow rate, and AVF location. OUTCOMES: AVF location; successful AVF/AVG use (≥30 days of continuous use); time-to-first successful AVF/AVG use (maturation). RESULTS: During DOPPS 1 to 5, the percentage of AVFs created in the lower arm was consistently ≥93% in Japan and 65% to 77% in Europe/ANZ, but in the United States, this value declined from 70% (DOPPS 1) to 32% (DOPPS 5). Patient characteristics associated with AVF location differed by region. Successful AVF use was 87% in Japan, 67% in Europe/ANZ, and 64% in the United States, whereas successful AVG use was 86%, 75%, and 78%, respectively. Successful AVF use was greater for upper- versus lower-arm AVFs in the United States, with little difference in Europe/ANZ and the opposite pattern in Japan. Median time until first successful AVF use was 10 days in Japan, 46 days in Europe/ANZ, and 82 days in United States; until first successful AVG use: 6, 24, and 29 days, respectively. LIMITATIONS: Potential measurement error related to chart data abstraction in multiple hemodialysis facilities. CONCLUSIONS: Large international differences exist in AVF location, predictors of AVF location, successful use of AVFs, and time to first AVF/AVG use, challenging what constitutes best practice. The large US shift from lower- to upper-arm AVFs raises serious concerns about long-term health implications for some patients and how policies and practices aimed at increasing AVF use have affected AVF placement location.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Pisoni RL, Zepel L, Fluck R, et al. International Differences in the Location and Use of Arteriovenous Accesses Created for Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2017. PMID: 29198387. doi:10.1053/j.ajkd.2017.09.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。